Sajjad A. Qureshi

3.1k citations

34 papers · 2.5k indexed · 1 hit paper · h-index 22

Oncology top 2%
Molecular Biology top 10%
Immunology top 2%
Cancer Research top 5%
Endocrinology, Diabetes and Metabolism top 5%

Co-authors: James Darnell Curt M. Horvath David Cowburn Ke Shuai Stewart Leung George R. Stark Ian M. Kerr J E Darnell
Topics: Receptor Mechanisms and Signaling (9 papers)Pancreatic function and diabetes (8 papers)Diabetes Treatment and Management (7 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States United Kingdom Pakistan

In The Last Decade

Sajjad A. Qureshi

32 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions

1994 709 citations Ke Shuai, Curt M. Horvath et al. Cell profile →

Peers

Countries citing papers authored by Sajjad A. Qureshi

Since Specialization

Citations

This map shows the geographic impact of Sajjad A. Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sajjad A. Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sajjad A. Qureshi more than expected).

Fields of papers citing papers by Sajjad A. Qureshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sajjad A. Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sajjad A. Qureshi. The network helps show where Sajjad A. Qureshi may publish in the future.

Co-authorship network of co-authors of Sajjad A. Qureshi

This figure shows the co-authorship network connecting the top 25 collaborators of Sajjad A. Qureshi. A scholar is included among the top collaborators of Sajjad A. Qureshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sajjad A. Qureshi. Sajjad A. Qureshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of Dexmedetomidine Combined with Bupivacaine in Supraclavicular Block Versus Bupivacaine alone in Upper Limb Surgery 2023 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),Sajjad A. Qureshi,(unknown)	0
2	A novel series of indazole-/indole-based glucagon receptor antagonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·Songnian Lin,Fengqi Zhang,Guoqiang Jiang,Sajjad A. Qureshi,Xiaodong Yang,Gary G. Chicchi,Laurie Tota,Alka Bansal,Edward J. Brady,Maria E. Trujillo,Gino Salituro,Corey Miller,James R. Tata,Bei B. Zhang,Emma R. Parmee	14
3	A Genome-Wide siRNA Screen to Identify Modulators of Insulin Sensitivity and Gluconeogenesis 2012 ·PLoS ONE ·Ruojing Yang,Raul Lacson,Gino Castriota,Xiaohua Douglas Zhang,Yaping Liu,Wenqing Zhao,Monica Einstein,Luiz Miguel Camargo,Sajjad A. Qureshi,Kenny K. Wong,Bei B. Zhang,Marc Ferrer,Joel P. Berger	3
4	Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist 2012 ·PLoS ONE ·James Mu,Sajjad A. Qureshi,Edward J. Brady,Eric S. Muise,Mari R. Candelore,Guoqiang Jiang,Zhihua Li,Margaret Wu,Xiaodong Yang,Qing Dallas-Yang,Corey Miller,Yusheng Xiong,Ronald B. Langdon,Emma R. Parmee,Bei B. Zhang	46
5	Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice 2011 ·Diabetologia ·James Mu,Guoqiang Jiang,E.J. Brady,Qing Dallas-Yang,Fang Liu,J H Woods,Emanuel Zycband,Michael Wright,(unknown),Kai Lü,Lan Zhu,Xun Shen,Ranabir SinhaRoy,(unknown),Sajjad A. Qureshi,(unknown),Fuquan Zhang,Emma R. Parmee,(unknown)	59
6	Spontaneous haemopneumothorax 2011 ·BMJ Case Reports ·Kelvin Kian Long Chong,Sajjad A. Qureshi,(unknown),She Lok	3
7	RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice 2010 ·International Journal of Obesity ·(unknown),Gino Castriota,(unknown),Michele A. Cleary,Kenneth Ellsworth,Myung K. Shin,(unknown),Thomas Vogt,Margaret Wu,Shihao Xu,Xiao-Dong Yang,(unknown),N. Berger,Sajjad A. Qureshi	48
8	Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists 2004 ·European Journal of Pharmacology ·Qing Dallas-Yang,Xiaolan Shen,Mathias Z. Strowski,Edward J. Brady,Richard Saperstein,Raymond E. Gibson,Deborah Szalkowski,Sajjad A. Qureshi,Mari R. Candelore,Judith E. Fenyk-Melody,Emma R. Parmee,Bei B. Zhang,Guoqiang Jiang	31
9	Detection of Glucagon-Dependent GTPγS Binding in High-Throughput Format 2002 ·Analytical Biochemistry ·Qing Dallas-Yang,Sajjad A. Qureshi,Dan Xie,Bei B. Zhang,Guoqiang Jiang	10
10	Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators 2000 ·Journal of Biological Chemistry ·Sajjad A. Qureshi,Victor Ding,Zhihua Li,Deborah Szalkowski,(unknown),Dan Xie,Richard Saperstein,Edward J. Brady,S.-E. W. Huskey,Xiaolan Shen,Kun Liu,Libo Xu,Gino Salituro,James V. Heck,David E. Moller,A. Brian Jones,Bei B. Zhang	56
11	A High-Throughput Assay to Identify Compounds That Can Induce Dimerization of the Erythropoietin Receptor 2000 ·Analytical Biochemistry ·(unknown),Haideh Motamedi,Mark David,Sajjad A. Qureshi	4
12	Function of Stat2 Protein in Transcriptional Activation by Alpha Interferon 1996 ·Molecular and Cellular Biology ·Sajjad A. Qureshi,Stewart Leung,Ian M. Kerr,George R. Stark,James Darnell	149
13	Role of STAT2 in the Alpha Interferon Signaling Pathway 1995 ·Molecular and Cellular Biology ·Stewart Leung,Sajjad A. Qureshi,Ian M. Kerr,James Darnell,George R. Stark	249
14	The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2 1995 ·Nucleic Acids Research ·Riqiang Yan,Sajjad A. Qureshi,Zhong Zhong,Zilong Wen,J E Darnell	52
15	Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactionsbreakdown → 1994 ·Cell ·Ke Shuai,Curt M. Horvath,(unknown),Sajjad A. Qureshi,David Cowburn,James Darnell	709
16	A Dominant Negative RAF-1 Mutant Prevents V-SRC-Induced Transformation 1993 ·Biochemical and Biophysical Research Communications ·Sajjad A. Qureshi,Cecil K. Joseph,(unknown),Jian Song,Ruchika Gupta,(unknown),Ulf R. Rapp,David A. Foster	19
17	v-Fps-responsiveness in the Egr-1 promoter is mediated by serum response elements 1992 ·Nucleic Acids Research ·Konstantina Alexandropoulos,Sajjad A. Qureshi,(unknown),Vikas P. Sukhatme,David A. Foster	29
18	Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-Src. 1992 ·Journal of Biological Chemistry ·Sajjad A. Qureshi,Konstantina Alexandropoulos,(unknown),Cecil K. Joseph,(unknown),Ulf R. Rapp,David A. Foster	37
19	Molecular nature of T-cell receptors. 1991 ·PubMed ·(unknown),Sajjad A. Qureshi	1
20	Evidence that v-src and v-fps gene products use a protein kinase C-mediated pathway to induce expression of a transformation-related gene. 1989 ·Proceedings of the National Academy of Sciences ·Rudolph Spangler,Christine L.M. Joseph,Sajjad A. Qureshi,Karen Berg,David A. Foster	50

About Sajjad A. Qureshi

Sajjad A. Qureshi is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Molecular Biology, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (9 papers), Pancreatic function and diabetes (8 papers) and Diabetes Treatment and Management (7 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.3k citations) and Cancer Research (338 citations). Sajjad A. Qureshi has collaborated with scholars based in United States, United Kingdom and Pakistan. Frequent co-authors include James Darnell, Curt M. Horvath, David Cowburn, Ke Shuai, Stewart Leung, George R. Stark, Ian M. Kerr, J E Darnell, M. Salditt-Georgieff and David A. Foster. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact